Presence of specific antibiotic (tet) resistance genes in infant faecal microbiota

Miguel Gueimonde1, Seppo Salminen, Erika Isolauri

  • 1Functional Foods Forum, University of Turku, Turku, Finland. mgueimonde@ipla.csic.es

Insights

Antibiotic resistance genes are common in the gut microbiota of healthy breast-fed infants and their mothers. Even without direct antibiotic exposure, these genes, particularly tet M, are prevalent, highlighting environmental reservoirs of resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Public Health

Background:

  • Antibiotic resistance is a growing global health concern.
  • While pathogen resistance is well-studied, the gut microbiota's role as a resistance reservoir is increasingly recognized.
  • Antibiotics impact both pathogens and commensal gut bacteria.

Purpose of the Study:

  • To investigate the prevalence of tetracycline resistance genes (tet) in the gut microbiota of healthy breast-fed infants and their mothers.
  • To characterize the gut microbiota composition in relation to antibiotic resistance genes.
  • To assess the potential for environmental transmission of resistance genes.

Main Methods:

  • Polymerase Chain Reaction (PCR) was used to detect specific tetracycline resistance genes (tet M, tet W, tet O, tet S, tet T, tet B).
  • Fluorescence In Situ Hybridization (FISH) was employed to characterize the gut microbiota composition.
  • Stool samples from exclusively breast-fed infants and their mothers were analyzed.

Main Results:

  • The tet M gene was detected in all infants and mothers.
  • tet O was found in all mothers but only 35% of infants.
  • tet W was present in 85% of mothers and 13% of infants; other tet genes were not detected.

Conclusions:

  • Antibiotic resistance genes are widespread in the gut microbiota, even in healthy individuals with no history of antibiotic exposure.
  • The mother-infant dyad appears to be a significant factor in the transmission of these resistance genes.
  • The gut microbiota serves as a reservoir for antibiotic resistance genes, emphasizing the need for broader strategies to combat antimicrobial resistance.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...